Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Roy Buchanan is an analyst at Citizens Capital Markets. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/18/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/14/2025 | INO | Buy Now | Inovio Pharmaceuticals | $2.09 | 761.24% | Roy Buchanan36% | $18 → $18 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/12/2025 | CDTX | Buy Now | Cidara Therapeutics | $22.40 | 105.36% | Roy Buchanan36% | → $46 | Initiates | → Market Outperform | Get Alert |
| 02/25/2025 | ANTX | Buy Now | AN2 Therapeutics | $1.39 | 259.71% | Roy Buchanan36% | $5 → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/14/2025 | CVAC | Buy Now | CureVac | $3.03 | 428.05% | Roy Buchanan36% | $16 → $16 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/13/2025 | TPG | Buy Now | TPG | $49.20 | — | Roy Buchanan36% | — | Reiterates | Market Perform → Market Perform | Get Alert |
| 02/11/2025 | ESPR | Buy Now | Esperion Therapeutics | $1.58 | 153.16% | Roy Buchanan36% | $7 → $4 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/11/2025 | ENTA | Buy Now | Enanta Pharma | $6.30 | 233.33% | Roy Buchanan36% | $21 → $21 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/03/2025 | ANTX | Buy Now | AN2 Therapeutics | $1.39 | 259.71% | Roy Buchanan36% | $5 → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 01/30/2025 | IRWD | Buy Now | Ironwood Pharmaceuticals | $1.50 | 833.33% | Roy Buchanan36% | $23 → $14 | Maintains | Market Outperform | Get Alert |
| 01/23/2025 | ESPR | Buy Now | Esperion Therapeutics | $1.58 | 343.04% | Roy Buchanan36% | $7 → $7 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 01/10/2025 | INO | Buy Now | Inovio Pharmaceuticals | $2.09 | 761.24% | Roy Buchanan36% | $18 → $18 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 01/10/2025 | ABVX | Buy Now | Abivax | $6.60 | 400% | Roy Buchanan36% | $33 → $33 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 11/26/2024 | ENTA | Buy Now | Enanta Pharma | $6.30 | 233.33% | Roy Buchanan36% | $22 → $21 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 11/21/2024 | HOOK | Buy Now | HOOKIPA Pharma | $1.31 | 434.35% | Roy Buchanan36% | $24 → $7 | Maintains | Market Outperform | Get Alert |
| 11/19/2024 | ANTX | Buy Now | AN2 Therapeutics | $1.39 | 259.71% | Roy Buchanan36% | $5 → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 10/09/2024 | ENTA | Buy Now | Enanta Pharma | $6.30 | 249.21% | Roy Buchanan36% | $22 → $22 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 10/01/2024 | GRTS | Buy Now | Gritstone Bio | — | — | Roy Buchanan36% | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 09/27/2024 | ENTA | Buy Now | Enanta Pharma | $6.30 | 249.21% | Roy Buchanan36% | $22 → $22 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 09/16/2024 | CVAC | Buy Now | CureVac | $3.03 | 428.05% | Roy Buchanan36% | $16 → $16 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/16/2024 | CVAC | Buy Now | CureVac | $3.03 | 428.05% | Roy Buchanan36% | $18 → $16 | Maintains | Market Outperform | Get Alert |
| 08/09/2024 | HOOK | Buy Now | HOOKIPA Pharma | $1.31 | 1732.06% | Roy Buchanan36% | $23 → $24 | Maintains | Market Outperform | Get Alert |
| 08/09/2024 | ANTX | Buy Now | AN2 Therapeutics | $1.39 | 115.83% | Roy Buchanan36% | $6 → $3 | Maintains | Market Outperform | Get Alert |
| 08/05/2024 | GRTS | Buy Now | Gritstone Bio | — | — | Roy Buchanan36% | $5 → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/02/2024 | ABUS | Buy Now | Arbutus Biopharma | $3.25 | 53.85% | Roy Buchanan36% | $4 → $5 | Maintains | Market Outperform | Get Alert |
| 07/03/2024 | CVAC | Buy Now | CureVac | $3.03 | 494.06% | Roy Buchanan36% | $18 → $18 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/14/2024 | GRTS | Buy Now | Gritstone Bio | — | — | Roy Buchanan36% | $5 → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/07/2024 | ENTA | Buy Now | Enanta Pharma | $6.30 | 249.21% | Roy Buchanan36% | $23 → $22 | Maintains | Market Outperform | Get Alert |
| 04/04/2024 | ABUS | Buy Now | Arbutus Biopharma | $3.25 | 23.08% | Roy Buchanan36% | $4 → $4 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/02/2024 | GRTS | Buy Now | Gritstone Bio | — | — | Roy Buchanan36% | $4 → $5 | Maintains | Market Outperform | Get Alert |
| 04/02/2024 | ANTX | Buy Now | AN2 Therapeutics | $1.39 | 331.65% | Roy Buchanan36% | → $6 | Upgrade | Market Perform → Market Outperform | Get Alert |
| 02/28/2024 | GRTS | Buy Now | Gritstone Bio | — | — | Roy Buchanan36% | → $4 | Initiates | → Market Outperform | Get Alert |
| 02/12/2024 | ANTX | Buy Now | AN2 Therapeutics | $1.39 | — | Roy Buchanan36% | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 01/04/2024 | INO | Buy Now | Inovio Pharmaceuticals | $2.09 | -52.15% | Roy Buchanan36% | → $12 | Initiates | → Market Outperform | Get Alert |
| 01/04/2024 | ANTX | Buy Now | AN2 Therapeutics | $1.39 | 2058.27% | Roy Buchanan36% | → $30 | Initiates | → Market Outperform | Get Alert |
| 11/21/2023 | ENTA | Buy Now | Enanta Pharma | $6.30 | 265.08% | Roy Buchanan36% | $42 → $23 | Maintains | Outperform | Get Alert |
| 11/03/2023 | DVAX | Buy Now | Dynavax Technologies | $13.90 | 94.24% | Roy Buchanan36% | $25 → $27 | Maintains | Market Outperform | Get Alert |
| 08/08/2023 | ENTA | Buy Now | Enanta Pharma | $6.30 | 566.67% | Roy Buchanan36% | $65 → $42 | Maintains | Market Outperform | Get Alert |
| 08/04/2023 | DVAX | Buy Now | Dynavax Technologies | $13.90 | 79.86% | Roy Buchanan36% | $24 → $25 | Maintains | Outperform | Get Alert |
| 07/18/2023 | PRDS | Buy Now | Pardes Biosciences | — | — | Roy Buchanan36% | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 07/06/2023 | ABUS | Buy Now | Arbutus Biopharma | $3.25 | 84.62% | Roy Buchanan36% | → $6 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/09/2023 | ENTA | Buy Now | Enanta Pharma | $6.30 | 931.75% | Roy Buchanan36% | $82 → $65 | Maintains | Outperform | Get Alert |
| 05/03/2023 | DVAX | Buy Now | Dynavax Technologies | $13.90 | 72.66% | Roy Buchanan36% | $25 → $24 | Maintains | Outperform | Get Alert |
| 04/26/2023 | CVAC | Buy Now | CureVac | $3.03 | 692.08% | Roy Buchanan36% | $34 → $24 | Maintains | Outperform | Get Alert |
| 03/29/2023 | ABUS | Buy Now | Arbutus Biopharma | $3.25 | 84.62% | Roy Buchanan36% | → $6 | Reiterates | → Market Outperform | Get Alert |
| 03/15/2023 | PRDS | Buy Now | Pardes Biosciences | — | — | Roy Buchanan36% | $9 → $5 | Maintains | Market Outperform | Get Alert |
| 03/06/2023 | ESPR | Buy Now | Esperion Therapeutics | $1.58 | 849.37% | Roy Buchanan36% | → $15 | Reiterates | → Market Outperform | Get Alert |
| 03/03/2023 | ARGX | Buy Now | argenx | $610.00 | -26.56% | Roy Buchanan36% | $443 → $448 | Maintains | Market Outperform | Get Alert |
| 03/01/2023 | CRMD | Buy Now | Cormedix | $10.43 | 53.4% | Roy Buchanan36% | $14 → $16 | Maintains | Market Perform | Get Alert |
| 02/24/2023 | DVAX | Buy Now | Dynavax Technologies | $13.90 | 79.86% | Roy Buchanan36% | $22 → $25 | Maintains | Market Outperform | Get Alert |
| 02/16/2023 | IBIO | Buy Now | iBio | $4.44 | — | Roy Buchanan36% | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 12/13/2022 | PRDS | Buy Now | Pardes Biosciences | — | — | Roy Buchanan36% | → $9 | Initiates | → Market Outperform | Get Alert |
| 11/17/2022 | CVAC | Buy Now | CureVac | $3.03 | 1022.11% | Roy Buchanan36% | $37 → $34 | Maintains | Market Outperform | Get Alert |
| 09/27/2022 | DVAX | Buy Now | Dynavax Technologies | $13.90 | 58.27% | Roy Buchanan36% | → $22 | Initiates | → Market Outperform | Get Alert |
| 08/09/2022 | ENTA | Buy Now | Enanta Pharma | $6.30 | 2074.6% | Roy Buchanan36% | $103 → $137 | Maintains | Market Outperform | Get Alert |
| 06/28/2022 | ABUS | Buy Now | Arbutus Biopharma | $3.25 | 176.92% | Roy Buchanan36% | $10 → $9 | Maintains | Market Outperform | Get Alert |
| 05/19/2022 | ENTA | Buy Now | Enanta Pharma | $6.30 | 1534.92% | Roy Buchanan36% | $114 → $103 | Maintains | Market Outperform | Get Alert |
| 05/10/2022 | ENTA | Buy Now | Enanta Pharma | $6.30 | 1709.52% | Roy Buchanan36% | $116 → $114 | Maintains | Market Outperform | Get Alert |
| 04/22/2022 | CVAC | Buy Now | CureVac | $3.03 | 1121.12% | Roy Buchanan36% | $52 → $37 | Maintains | Market Outperform | Get Alert |
| 01/18/2022 | CVAC | Buy Now | CureVac | $3.03 | 1616.17% | Roy Buchanan36% | → $52 | Initiates | → Market Outperform | Get Alert |
| 12/21/2021 | ARGX | Buy Now | argenx | $610.00 | -31.48% | Roy Buchanan36% | $368 → $418 | Maintains | Market Outperform | Get Alert |
| 11/29/2021 | IBIO | Buy Now | iBio | $4.44 | -66.22% | Roy Buchanan36% | → $750 | Initiates | → Outperform | Get Alert |
| 09/14/2021 | PYPD | Buy Now | PolyPid | $2.81 | 398.22% | Roy Buchanan36% | → $420 | Initiates | → Market Outperform | Get Alert |
| 08/06/2021 | ENTA | Buy Now | Enanta Pharma | $6.30 | 1122.22% | Roy Buchanan36% | $70 → $77 | Maintains | Market Outperform | Get Alert |
